8-K: Grown Rogue Reports 2025 Results, Eyes 2026 Growth

Sentiment:

Results of Operations and Financial Condition


Grown Rogue International Inc. announced preliminary 2025 financial results, showing a 22% revenue increase to $32.4 million and a 42% rise in Adjusted EBITDA to $5.4 million, while also providing 2026 guidance.

Summary

  • Grown Rogue International Inc. reported preliminary unaudited financial results for the year ended December 31, 2025, and provided financial guidance for 2026.
  • Full-year 2025 revenue reached $32.4 million, a 22% increase from $26.6 million in 2024, driven by the New Jersey market entry, though partially offset by pricing pressures in Michigan and Oregon.
  • Adjusted EBITDA (non-GAAP) for 2025 was $5.4 million (16.5% margin), a 42% increase from $3.8 million in 2024.
  • GAAP net income for 2025 was $3.2 million, which included a significant non-cash gain from derivative liabilities.
  • The company is transitioning to U.S. GAAP reporting and has consolidated its New Jersey operations.
  • Expansion projects are underway in New Jersey, and new facilities are under construction in Minnesota and Illinois.
  • Guidance for 2026 anticipates revenue between $32 million and $35 million, and Adjusted EBITDA between $6 million and $8 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing, highlighting revenue and EBITDA growth, strategic expansion, and clear future guidance, while acknowledging ongoing market challenges and pricing pressures.

Positives

  • Full-year 2025 revenue increased by 22% to $32.4 million compared to $26.6 million in 2024.
  • Adjusted EBITDA (non-GAAP) grew by 42% to $5.4 million in 2025, with a margin of 16.5%.
  • Successful entry and sell-through of branded products in the New Jersey market.
  • New Jersey expansion (Phase II) is progressing, expected to add 25% to capacity with first harvest in May.
  • Production costs for dry-weight cannabis biomass in mature facilities remained below $225 per pound.
  • Secured $12.0 million in aggregate principal from its senior secured credit facility in 2025.
  • Anticipates revenue growth of over 20% in Q1 2026 compared to Q1 2025, primarily driven by New Jersey.
  • Modest improvement in volume and price trends observed in Oregon in Q1 2026.

Negatives

  • Significant pricing pressure contributed to revenue declines of 22% in Michigan and 8% in Oregon for the full year 2025.
  • Termination of the Vireo consulting agreement in September 2024 impacted revenue.
  • Higher corporate overhead associated with growth initiatives affected Adjusted EBITDA.
  • Q4 2025 reported a GAAP net loss of ($2.1) million.
  • Michigan experienced additional market disruption due to a new wholesale tax implemented on January 1, 2026.
  • Oregon and Michigan markets continue to face intense pricing pressure.
  • The transition to GAAP reporting and consolidation of ABCO may affect comparability with prior periods.

Risks

  • Intense pricing pressure in Michigan and Oregon markets continues to impact revenue and profitability.
  • Market disruption in Michigan following the implementation of a new wholesale tax.
  • The Company's operations in the United States are subject to U.S. federal law, which currently deems cannabis illegal.
  • Future results are subject to risks and uncertainties, including changes in general economic, business, and political conditions.
  • Access to debt or equity capital on acceptable terms could be a challenge.
  • Adverse changes in the public perception of cannabis.
  • Regulatory developments and the timing or availability of required approvals for new market entries and expansions.
  • The pace and cost of construction, commissioning, and ramp-up activities for new facilities.

Future Outlook

Grown Rogue is introducing a multi-year growth framework with long-term (3-5 year) objectives and annual financial guidance. For 2026, the company guides for revenue of $32-$35 million and Adjusted EBITDA of $6-$8 million. For 2027, revenue is projected at $50-$58 million and Adjusted EBITDA at $14-$18 million. Long-term targets include 25% annual compounded revenue growth and 35% annual compounded profit growth, with a Return on Incremental Invested Capital (ROIIC) greater than 75%.

Management Comments

  • "2025 was focused on growth and investment for the future with our commitments in new markets and additions to our team, while staying grounded in what we do best: consistently delivering craft-quality flower, supported by a cost structure designed to compete through price normalization."
  • "Across Oregon and Michigan, pricing pressure remains intense, and we responded by sharpening execution and tightening cost controls, noting our overall cost of production for indoor biomass in these markets is below $225 per pound, while maintaining our passion for quality flower."
  • "Our growth plan is focused on disciplined capital allocation and targeted returns."
  • "We are introducing targets for profit growth and incremental returns to make our priorities more measurable, while maintaining flexibility to act on distressed opportunities that meet our underwriting criteria."
  • "Year-end 2025 marks our transition to GAAP reporting and the consolidation of ABCO within our financial statements."

Industry Context

StockSavvy.ai notes that Grown Rogue's transition to U.S. GAAP and the provision of detailed financial guidance reflect a maturing approach to financial reporting, common among U.S.-listed cannabis companies seeking greater investor confidence. The company's strategy of expanding into new markets like New Jersey, Minnesota, and Illinois while navigating pricing pressures in established markets like Oregon and Michigan is a prevalent theme across the industry.

Comparison to Industry Standards

  • Grown Rogue's full-year 2025 revenue of $32.4 million positions it as a mid-tier player within the U.S. cannabis market, which features a wide range of company sizes.
  • The 22% year-over-year revenue growth is strong, especially considering the pricing headwinds in key markets, and generally outperforms companies solely reliant on mature, price-compressed markets.
  • The Adjusted EBITDA margin of 16.5% is competitive, though it varies significantly by state and operational efficiency. Companies like Curaleaf or Trulieve often report higher margins in their most efficient markets, but Grown Rogue's focus on craft quality may command premium pricing in certain segments.
  • The company's production cost of dry-weight cannabis biomass below $225 per pound is a key efficiency metric. Industry benchmarks for indoor cultivation can range from $150 to $400+ per pound depending on technology, scale, and location. Grown Rogue's cost is on the lower end for indoor operations, indicating strong operational control.
  • The planned expansion to approximately 58,000 sq ft of flowering canopy by the end of 2026 from 37,000 sq ft currently represents aggressive capacity growth, aligning with companies focused on scaling rapidly in new or underserved markets.

Stakeholder Impact

  • Shareholders: The company's financial performance and future guidance will impact shareholder value. The transition to GAAP and provision of detailed long-term objectives aim to improve transparency and investor confidence.
  • Employees: Continued growth and expansion may lead to job creation. Operational efficiency and cost control measures could impact workforce management.
  • Suppliers: Increased production capacity and market expansion will likely lead to higher demand for raw materials and services.
  • Creditors: The company's financial health and ability to meet debt obligations are crucial. The secured credit facility and cash position are relevant to creditors.

Next Steps

  • Host conference call and webcast on April 7, 2026, to discuss results.
  • File audited Annual Report on Form 10-K by April 8, 2026.
  • Complete remaining flower rooms in New Jersey's Phase II expansion incrementally through the remainder of 2026.
  • Commence revenue generation from the Illinois facility in Q4 2026.
  • Bring Phase I of the Minnesota cultivation facility online in late Q3 2026, with revenue expected in Q1 2027.
  • Expand Illinois flowering canopy from 5,000 to 14,000 sq ft and Minnesota from 8,000 to approximately 16,000 sq ft in mid-2027.

Key Dates

DateDescription
2024-09-01Termination of Vireo consulting agreement.
2024-12-11New Jersey operations commenced first sales.
2025-12-31Year-end for preliminary financial results.
2026-01-01Implementation of new wholesale tax in Michigan.
2026-04-07Date of the 8-K filing and press release announcing preliminary results and hosting a conference call.
2026-04-08Expected filing date for the audited Annual Report on Form 10-K.
2026-05-01Expected first harvest from the first flower room of the New Jersey Phase II expansion.
2026-07-01Anticipated online date for Phase I of the Minnesota cultivation facility (late Q3 2026).

Recommendation

hold

The company shows positive revenue and EBITDA growth, driven by strategic expansion into new markets. However, persistent pricing pressures in established markets and the inherent risks of the cannabis industry warrant a cautious approach. The clear guidance and long-term outlook are positive, but execution risk remains. A 'hold' recommendation reflects a balanced view of growth potential against current market challenges.

Keywords

Grown Rogue International, Cannabis, Financial Results, 8-K Filing, GAAP Reporting, Adjusted EBITDA, New Jersey Market, Oregon Operations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.